首页> International journal of radiation oncology, biology, physics> In Reply to Sari et al.

In Reply to Sari et al.

导出原文传递

翻译打印收藏纠错

第一作者： Bjørg Y,Aksnessæther

第一单位： Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

作者： Bjørg Y,Aksnessæther ^[1] ; Tor Åge,Myklebust ^[2] ; Arne,Solberg ^[3] ; Olbjørn H,Klepp ^[4] ; Eva,Skovlund ^[5] ; Solveig Roth,Hoff ^[6] ; Sophie D,Fosså ^[7] ; Anders,Widmark ^[8] ; Jo-Åsmund,Lund ^[1]

作者单位： Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. ^[1] Department of Research and Innovation, Møre and Romsdal Hospital Trust, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway. ^[2] Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway. ^[3] Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway. ^[4] Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. ^[5] Department of Radiology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway. ^[6] Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. ^[7] Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden. ^[8]

医学主题词随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);肿瘤, 继发原发性(Neoplasms, Second Primary);前列腺肿瘤(Prostatic Neoplasms);肿瘤抑制蛋白质类(Tumor Suppressor Proteins)

DOI 10.1016/j.ijrobp.2020.02.027

PMID 32112877

发布时间 2021-02-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交